Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-8-27
pubmed:abstractText
We report here the results of fetal cell enrichment from maternal blood in 58 pregnant women by the use of magnetic activated cell sorting (MACS) with erythroblast-specific and/or maternal cell specific antibodies. Two approaches were compared; one-step MACS to enrich CD71+ (a membrane-bound marker) or GPA+ (another marker, glycophorin A) fetal cells versus two-step MACS to deplete CD14+ maternal cells and subsequently to enrich fetal (CD71+ or GPA+) cells. The existence of fetal cells was ensured by both FISH with Y-specific probes and karyotyping of respective amniotic and/or chorionic vullus cells, the results being applied for comparison of detection rate for XY fetuses between the two MACS procedures. In 24 (38.8%) of the 58 blood samples examined, Y-positive cells were observed by FISH, whereas there were 38 true XY fetuses later confirmed by karyotyping, including two cases of 47,XY,+21. On the other hand, in Y-negative cells by FISH, there were two cases of 47,XX,+18. The average number of cells sorted did not differ among one-step MACS procedures with anti-CD14, anti-CD71 and anti-GPA antibodies. With the latter, 12 (75%) of 16 Y-positive fetuses were detected, while only one (20%) of 5 Y-positive fetuses was detected by two-step MACS with anti-CD14/anti-GPA antibodies. The detection rate significantly varied (p = 0.0024) between the two procedures, although the numbers of cases examined were small. There was no statistical difference (p > 0.05) between one-step and two-step MACS with other combinations of antibodies. These findings indicate that one-step MACS using the anti-GPA antibody is more effective than two step MACS for enrichment of fetal cells from maternal blood.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0914-3505
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
120-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12196708-Adult, pubmed-meshheading:12196708-Antibody Specificity, pubmed-meshheading:12196708-Antigens, CD, pubmed-meshheading:12196708-Antigens, Differentiation, B-Lymphocyte, pubmed-meshheading:12196708-Chromosome Mapping, pubmed-meshheading:12196708-Chromosomes, Human, Pair 18, pubmed-meshheading:12196708-Female, pubmed-meshheading:12196708-Fetal Blood, pubmed-meshheading:12196708-Fetus, pubmed-meshheading:12196708-Hematopoietic Stem Cells, pubmed-meshheading:12196708-Humans, pubmed-meshheading:12196708-Immunomagnetic Separation, pubmed-meshheading:12196708-In Situ Hybridization, Fluorescence, pubmed-meshheading:12196708-Karyotyping, pubmed-meshheading:12196708-Maternal Age, pubmed-meshheading:12196708-Pregnancy, pubmed-meshheading:12196708-Pregnancy, High-Risk, pubmed-meshheading:12196708-Receptors, Transferrin
pubmed:year
2002
pubmed:articleTitle
Enrichment of fetal cells from maternal blood by magnetic activated cell sorting (MACS) with fetal cell specific antibodies: one-step versus two-step MACS.
pubmed:affiliation
Department of Obstetrics and Gynecology, Nagoya City University Medical School, Aichi 467-8601, Japan. zhaoxx@med.nagoya-cu.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't